Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belarus
  Belgium
  Benin
  Brazil
  Bulgaria
  Cameroon
  Canada
  Chile
  China
  Colombia
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Finland
  France
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Ireland
  Israel
  Italy
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lithuania
  Luxembourg
  Malta
  Mexico
  Montenegro
  Morocco
  Namibia
  Netherlands
  Nigeria
  Norway
  Peru
  Poland
  Portugal
  Romania
  Russia
  Senegal
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tunisia
  Turkey
  Ukraine
  United Kingdom
  United States


  

Last Update: 05-07-2012  
Related category(ies):
Success stories  |  Special Collections  |  Research policy

 

Countries involved in the project described in the article:
Belgium  |  China  |  France  |  Germany  |  Ireland  |  Israel  |  Spain  |  Sweden
Add to PDF "basket"

GLYCOHIT – A hard-hitting group tackles cancer markers

One of the aims of EU research funding is to act as a catalyst for communication and the generation of novel ideas and collaborations. A case in point is the GlycoHIT project, which features an international team, including European researchers, working towards solving the puzzle of carbohydrate biomarkers in cancer.

©Fotolia
© Fotolia

All cells and most proteins in blood are 'glycosylated' – that is they are coated with glycans, or carbohydrates – and these carbohydrates are known to be altered in many diseases, including cancer.

"Current technologies for carbohydrate biomarker detection are very sophisticated and very expensive, requiring a high level of technical expertise," explains Professor Lokesh Joshi, Stokes Professor of GlycoSciences at the National University of Ireland Galway. "There is therefore a need to enable simpler, cheaper but reliable methods to detect carbohydrate markers of diseases, including diagnostic markers for cancer."

Professor Joshi is Coordinator of the EU-funded GlycoHIT project, which has set out to develop technologies enabling faster and more accurate analysis of glycosylation in blood samples from cancer patients.

"Our group is developing new technologies and molecules to achieve these goals," he says. "We are an international consortium with partners from Europe, Israel, China, Japan and the USA, working together towards common scientific objectives, but also training PhD students and postdoctoral researchers, and maintaining a gender-balanced research team."

Good science means good teamwork
Science, at its best, is and always has been a collaborative endeavour, but while there are strong national research programmes in place around Europe and indeed around the world, these tend to focus their support on researchers within their own borders. Professor Joshi says, "Ambitious projects like GlycoHIT need a spectrum of skills from a range of disciplines. No single country has the leading experts in all the disciplines that need to be combined.

"EU support is absolutely essential to make multi-disciplinary international and intercontinental collaborative efforts possible," he explains. "It means we can select our team members as we see fit, irrespective of their nationality or location. In this way, the best possible team is assembled by connecting with and bringing together a wide-ranging group of scientists from several countries."

Making sure it is useful One of the founding principles of GlycoHIT is to incorporate innovative ideas into existing science and technology, with each contributor determined to take the resulting knowledge and new technologies to the next level.

"Innovation, in the context of GlycoHIT", says Professor Joshi, "means discovering and testing real solutions for the biomedical field. We are doing exciting new basic research, which we hope to translate into relevant tools and techniques, with good potential for clinical and other applications."

Specific steps being taken by GlycoHIT to maximise innovation potential include, first, involving key players throughout the project, including participants from both industry and the clinical fields, thus ensuring the scientific results are relevant.

Second, the project is focusing on exciting new biomarkers with good real-world potential, and it will apply its results to the development of new sensors that can underpin viable diagnostic tools.

"Finally", Professor Joshi concludes, "GlycoHIT is working to raise the awareness of our work through dissemination, briefings, publications, etc. Such dissemination increases the interest and demand for our project innovations, as well as informing and, hopefully, inspiring other researchers to build on our work."

Project details

  • Participants: Ireland (Coordinator), China, Belgium, France, Germany, Israel, Japan, Norway, Spain, Sweden, United States
  • FP7 Proj. N° 260600
  • Total costs: € 4 878 903
  • EU contribution: € 2 993 056
  • Duration: January 2011 - December 2013

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

Project web site

Project information on CORDIS

Contacts
Unit A1 - External & internal communication,
Directorate-General for Research & Innovation,
European Commission
Tel : +32 2 298 45 40
  Top   Research Information Center